Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Feb 1;25(2):159-170.
doi: 10.1097/PCC.0000000000003346. Epub 2024 Jan 19.

Resuscitation With Vitamin C, Hydrocortisone, and Thiamin in Children With Septic Shock: A Multicenter Randomized Pilot Study

Collaborators, Affiliations
Randomized Controlled Trial

Resuscitation With Vitamin C, Hydrocortisone, and Thiamin in Children With Septic Shock: A Multicenter Randomized Pilot Study

Luregn J Schlapbach et al. Pediatr Crit Care Med. .

Abstract

Objectives: Adjunctive therapy with vitamin C, hydrocortisone, and thiamin has been evaluated in adults, but randomized controlled trial (RCT) data in children are lacking. We aimed to test the feasibility of vitamin C, hydrocortisone, and thiamin in PICU patients with septic shock; and to explore whether the intervention is associated with increased survival free of organ dysfunction.

Design: Open-label parallel, pilot RCT multicenter study. The primary endpoint was feasibility. Clinical endpoints included survival free of organ dysfunction censored at 28 days and nine secondary outcomes, shock reversal, and two proxy measures of intervention efficacy.

Setting: Six PICUs in Australia and New Zealand.

Patients: Children of age between 28 days and 18 years requiring vasoactive drugs for septic shock between August 2019 and March 2021.

Interventions: Patients were assigned 1:1 to receive 1 mg/kg hydrocortisone every 6 hours (q6h), 30 mg/kg ascorbic acid q6h, and 4 mg/kg thiamin every 12 hours (n = 27), or standard septic shock management (n = 33).

Measurements and main results: Sixty of 77 (78%) eligible patients consented with 91% of approached parents providing consent. The median time from randomization to intervention was 44 (interquartile range [IQR] 29-120) min. Seventy of seventy-seven (28%) patients had received IV steroids before randomization. Median survival alive and free of organ dysfunction was 20.0 (0.0-26.0) days in the intervention and 21.0 (0.0-25.0) days in the standard care group. Median PICU length of stay was 5.3 (2.5-11.3) days in the intervention group versus 6.9 (3.0-11.5) days in the control group. Shock reversal occurred at a median of 35.2 (14.6-101.2) hours in the intervention group versus 47.3 (22.4-106.8) hours in the standard care group (median difference -12 hr; 95% CI, -56.8 to 32.7 hr).

Conclusions: In children requiring vasopressors for septic shock, a protocol comparing adjunctive treatment with high-dose vitamin C, hydrocortisone, and thiamin versus standard care was feasible. These findings assist in making modifications to the trial protocol to enable a better-designed larger RCT.

PubMed Disclaimer

Conflict of interest statement

Drs. Schlapbach and Long received funding from the National Health and Medical Research Council Practitioner Fellowship, the Children`s Hospital Foundation, the Emergency Medicine Foundation Queensland, Financial Markets for Children Australia, the Gold Coast Hospital Foundation, and Children’s Health Queensland Study, Education and Research Trust Account grant. Dr. George’s institution received funding from Gold Coast Hospital Foundation and Emergency Medicine Foundation. Drs. Singh and Festa’s institution received funding from the University of Queensland. The remaining authors have disclosed that they do not have any potential conflicts of interest.

Figures

Figure 1.
Figure 1.
Consolidated Standards of Reporting Trials participant flow diagram for the Resuscitation in Paediatric Sepsis using Metabolic Resuscitation—a Randomized Controlled Pilot Study in the PICU trial.
Figure 2.
Figure 2.
Cumulative incidence functions for survival free of organ dysfunction (accounting for mortality) for the study cohort. Hydrocort = hydrocortisone, Vit C = vitamin C.

References

    1. Rudd KE, Johnson SC, Agesa KM, et al. : Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the global burden of disease study. Lancet. 2020; 395:200–211 - PMC - PubMed
    1. Agyeman PKA, Schlapbach LJ, Giannoni E, et al. ; Swiss Pediatric Sepsis Study: Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: A population-based cohort study. Lancet Child Adolesc Health. 2017; 1:124–133 - PubMed
    1. Moynihan KM, Alexander PMA, Schlapbach LJ, et al. ; Australian and New Zealand Intensive Care Society Pediatric Study Group (ANZICS PSG) and the ANZICS Centre for Outcome and Resource Evaluation (ANZICS CORE): Epidemiology of childhood death in Australian and New Zealand intensive care units. Intensive Care Med. 2019; 45:1262–1271 - PubMed
    1. Maddux AB, Zimmerman JJ, Banks RK, et al. ; Life After Lapse Sepsis Evaluation (LAPSE) Investigators: Health resource use in survivors of pediatric septic shock in the United States. Pediatr Crit Care Med. 2022; 23:e277–e288 - PMC - PubMed
    1. Schlapbach LJ, MacLaren G, Festa M, et al. ; Australian & New Zealand Intensive Care Society (ANZICS) Centre for Outcomes & Resource Evaluation (CORE) and Australian & New Zealand Intensive Care Society (ANZICS) Paediatric Study Group: Prediction of pediatric sepsis mortality within 1 h of intensive care admission. Intensive Care Med. 2017; 43:1085–1096 - PubMed

Publication types